With increasing frequency over the past few years, optometrists across the country have gotten referrals from internists requesting baseline diabetic retinopathy (DR) screenings for patients about to start therapy with one of the glucagon-like peptide-1 (GLP-1)/glucose-dependent insulinotropic polypeptide (GIP) receptor agonists such as semaglutide (Ozempic, Novo Nordisk), tirzepatide (Mounjaro, Eli Lilly) and dulaglutide (Trulicity, Eli Lilly
Injectable use involves sterile technique, correct dilution, precise measurement, and medical screening
This isn't about another miracle weight loss solution
The company generates top-tier industry financial results with gross margins of 32%, projected EBITDA of $400 million and earnings forecasted to grow at a double-digit pace over the next five years
Users of the drugs are advised to eat small, regular meals with lots of fibre and protein as they adjust to healthier eating habits
Furthermore, Pendulum has taken the step of funding or sponsoring clinical trials of its products, in which participants saw such improvements as lower hemoglobin A1c and reduced fatigue and bloating.27 28 Notwithstanding the potential bias that self-conducted studies may have, these trials give us insight into Pendulums efficacy that other brands have not provided, and which may not have come to light without Pendulums funding